About Dermapharm
Dermapharm is a company based in Grunwald (Germany) founded in 1991. The company has 3,600 employees as of December 31, 2024. Dermapharm has completed 10 acquisitions, including AllergoPharma, Arkopharma and Axicorp. Dermapharm offers products and services including Vitamin D Supplements and Herpes Treatment Device.
- Headquarter Grunwald, Germany
- Employees 3600 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Dermapharm Holding Se
-
Annual Revenue
$1.23 B (USD)4as on Dec 31, 2024
-
Net Profit
$118.22 M (USD)82.44as on Dec 31, 2024
-
EBITDA
$309.47 M (USD)-2.31as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
3600
as on Dec 31, 2024
-
Investments & Acquisitions
AllergoPharma
& 9 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Dermapharm
Dermapharm is a publicly listed company on the XETR with ticker symbol DMP in Germany, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Dermapharm
Dermapharm offers a comprehensive portfolio of products and services, including Vitamin D Supplements and Herpes Treatment Device.
Vitamin D supplements are provided for immune system support and individualized dosing in various health applications.
A herpes treatment device is offered for managing lip herpes through warmth application.
Funding Insights of Dermapharm
Detailed funding history for Dermapharm
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dermapharm
Dermapharm has strategically engaged in corporate development activities, having acquired 10 companies. Notable acquisitions include AllergoPharma, Arkopharma and Axicorp.
Investment portfolio details for Dermapharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Nutritional products are provided as a private label brand.
|
Locked | Locked | 2015 | Locked | |
|
OTC drugs are manufactured by Axicorp in Germany.
|
Locked | Locked | 2002 | Locked | |
|
Satellite components and launch structures are manufactured for space missions.
|
Locked | Locked | 1980 | Locked |
Complete acquisition details for Dermapharm
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Dermapharm
Detailed financials for Dermapharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dermapharm Comparisons
Peer comparison for Dermapharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dermapharm
Detailed competitors of Dermapharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dermapharm
Complete news archive for Dermapharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dermapharm
Dermapharm was founded in 1991.
Dermapharm is headquartered in Grunwald, Germany. It is registered at Grunwald, Bavaria, Germany.
Wilhelm Beier is the current CEO of Dermapharm.
As of Dec 31, 2024, the latest employee count at Dermapharm is 3,600.
Annual revenue of Dermapharm is $1.23B as on Dec 31, 2024.
Dermapharm was founded in 1991 and is headquartered in Grunwald, Germany. Operations center on the pharmaceutical sector, with development and production of medications for skin conditions, allergies, and related health issues. The product range encompasses topical dermatological treatments and vitamin supplements. Patient support resources and educational materials are offered to assist users. Focus remains on standard healthcare solutions within the industry.
Dermapharm offers Vitamin D Supplements and Herpes Treatment Device.
Yes, Dermapharm is publicly traded on XETR under the ticker symbol DMP.
Dermapharm has made 10 acquisitions, including AllergoPharma, Arkopharma, and Axicorp.
The ticker symbol of Dermapharm is DMP on XETR.